Leveraging Methylated DNA Markers (MDMs) in the Detection of Endometrial Cancer, Ovarian Cancer, and Cervical Cancer: A Phase II Clinical Study

A Phase II/III Study of Paclitaxel/Carboplatin Alone or Combined with Either Trastuzumab and Hyaluronidase-oysk (HERCEPTIN HYLECTA) or Pertuzumab, Trastuzumab, and Hyaluronidase-zzxf (PHESGO) in HER2 Positive, Stage I-IV Endometrial Serous Carcinoma or Carcinosarcoma

A Phase II Study Of Tailored Adjuvant Therapy In Pole-Mutated And P53-Wildtype/Nsmp Early-Stage Endometrial Cancer (Rainbo Blue & Taper) Substudy A: Rainbo Polemut-Blue: Refining Adjuvant Treatment In Endometrial Cancer Based On Molecular Features (Rainbo) Transportec Platform Trials. Substudy B: Tailored Adjuvant Therapy In P53-Wildtype/Nsmp Early-Stage Endometrial Cancer (Taper)